190 related articles for article (PubMed ID: 7826905)
21. Long-term follow-Up of the italian trial of interferon-alpha versus conventional chemotherapy in chronic myeloid leukemia. The Italian Cooperative Study Group on Chronic Myeloid Leukemia.
Blood; 1998 Sep; 92(5):1541-8. PubMed ID: 9716581
[TBL] [Abstract][Full Text] [Related]
22. Hairy cell leukemia. An update on a cohort of 93 patients treated in a single institution. Effects of interferon in patients relapsing after splenectomy and in patients with or without maintenance treatment.
Troussard X; Flandrin G
Leuk Lymphoma; 1994; 14 Suppl 1():99-105. PubMed ID: 7820062
[TBL] [Abstract][Full Text] [Related]
23. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
[TBL] [Abstract][Full Text] [Related]
24. [Effectiveness of gamma interferon and alpha interferon in hairy cell leukemia].
Niederle N; Doberauer C; Kloke O; Höffken K; Schmidt CG
Klin Wochenschr; 1987 Jul; 65(14):706-12. PubMed ID: 3114551
[TBL] [Abstract][Full Text] [Related]
25. Extended follow-up of patients with hairy cell leukemia after treatment with cladribine.
Goodman GR; Burian C; Koziol JA; Saven A
J Clin Oncol; 2003 Mar; 21(5):891-6. PubMed ID: 12610190
[TBL] [Abstract][Full Text] [Related]
26. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
27. Alpha-interferon in hairy cell leukemia: an initial Indian experience.
Malhotra H; Advani SH; Gopal R; Saikia TK; Nadkarni KS; Pai VR; Nair CN
J Assoc Physicians India; 1992 Mar; 40(3):159-61. PubMed ID: 1634479
[TBL] [Abstract][Full Text] [Related]
28. Response duration and recovery of CD4+ lymphocytes following deoxycoformycin in interferon-alpha-resistant hairy cell leukemia: 7-year follow-up.
Seymour JF; Talpaz M; Kurzrock R
Leukemia; 1997 Jan; 11(1):42-7. PubMed ID: 9001417
[TBL] [Abstract][Full Text] [Related]
29. The Italian experience in the treatment of HCL. Italian Cooperative Group for HCL.
Damasio EE; Federico M
Hematol Oncol; 1993; 11 Suppl 1():42-9. PubMed ID: 8486342
[No Abstract] [Full Text] [Related]
30. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
Lauria F; Foà R; Raspadori D; Zinzani PL; Buzzi M; Fierro MT; Bonferroni M; Fanin R; Gallizia C; Michieli MG
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
[TBL] [Abstract][Full Text] [Related]
31. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
32. Three years' continuous low-dose interferon-alpha treatment of hairy-cell leukaemia: evaluation of response and maintenance dose.
Nielsen B; Braide I
Eur J Haematol; 1992 Oct; 49(4):174-9. PubMed ID: 1343089
[TBL] [Abstract][Full Text] [Related]
33. Splenectomy vs. alpha interferon: a randomized study in patients with previously untreated hairy cell leukemia.
Smalley RV; Connors J; Tuttle RL; Anderson S; Robinson W; Whisnant JK
Am J Hematol; 1992 Sep; 41(1):13-8. PubMed ID: 1503094
[TBL] [Abstract][Full Text] [Related]
34. Long-term outcome of hairy cell leukemia treated with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Vehling-Kaiser U; Wolf-Hornung B; Hill W; Heinemann V
Ann Hematol; 1999 Mar; 78(3):139-44. PubMed ID: 10211756
[TBL] [Abstract][Full Text] [Related]
35. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
36. Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy.
Pangalis GA; Boussiotis VA; Kittas C; Panayiotidis PG; Loukopoulos D; Fessas P; Mitsoulis-Mentzikoff C
Blood; 1991 Sep; 78(5):1385. PubMed ID: 1878598
[No Abstract] [Full Text] [Related]
37. Long-lasting complete remission in patients with hairy cell leukemia treated with 2-CdA: a 5-year survey.
Lauria F; Rondelli D; Zinzani PL; Bocchia M; Marotta G; Salvucci M; Raspadori D; Ventura MA; Birtolo S; Forconi F; Tura S
Leukemia; 1997 May; 11(5):629-32. PubMed ID: 9180283
[TBL] [Abstract][Full Text] [Related]
38. Hairy cell leukemia: a clinical review based on 725 cases of the Italian Cooperative Group (ICGHCL). Italian Cooperative Group for Hairy Cell Leukemia.
Frassoldati A; Lamparelli T; Federico M; Annino L; Capnist G; Pagnucco G; Dini E; Resegotti L; Damasio EE; Silingardi V
Leuk Lymphoma; 1994 Apr; 13(3-4):307-16. PubMed ID: 7519510
[TBL] [Abstract][Full Text] [Related]
39. Hairy cell leukemia--results with alpha interferon therapy.
Pai S; Shinde SC; Saikia TK; Gopal R; Nair CN; Advani SH
J Assoc Physicians India; 1999 Jun; 47(6):605-7. PubMed ID: 10999157
[TBL] [Abstract][Full Text] [Related]
40. Durability of responses to interferon alfa-2b in advanced hairy cell leukemia.
Ratain MJ; Golomb HM; Bardawil RG; Vardiman JW; Westbrook CA; Kaminer LS; Lembersky BC; Bitter MA; Daly K
Blood; 1987 Mar; 69(3):872-7. PubMed ID: 3814819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]